Journal of Dermatology for Physician Assistants

The official journal of the Society of Dermatology Physician Assistants

#02-Efficacy and Tolerability of Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis Involvement on the Face, Intertriginous, or Genital Areas: A Post-hoc Analysis of Phase 3 Trials

SDPA Presents 20th Annual Fall Dermatology Conference–Abstracts and Posters

November Read more

#05-Improving Patient Selection for Adjuvant Therapy: Considerations for the Role of the 31-gene Expression Profile

SDPA Presents 20th Annual Fall Dermatology Conference–Abstracts and Posters

November Read more

#08-Exposure–Response Analysis Demonstrates Response to Tapinarof is Driven by Local Effects at Sites of Application

SDPA Presents 20th Annual Fall Dermatology Conference–Abstracts and Posters

November Read more

#07-Validation of a Handheld Elastic-scattering Spectroscopy Device on Lesions Suggestive of Melanoma

SDPA Presents 20th Annual Fall Dermatology Conference–Abstracts and Posters

November Read more

#06-Demodex Mites in Patients with Non-melanoma Skin Cancer

SDPA Presents 20th Annual Fall Dermatology Conference–Abstracts and Posters

November Read more

#12-Effects of Ruxolitinib Cream on Patient-Reported Quality of Life in Atopic Dermatitis: 52-Week Pooled Results from Two Phase 3 Studies

SDPA Presents 20th Annual Fall Dermatology Conference–Abstracts and Posters

November Read more

#11-Efficacy of Spesolimab for Generalized Pustular Psoriasis (GPP) Flare Treatment According to GPP Area and Severity Index (GPPASI) Score at Baseline

SDPA Presents 20th Annual Fall Dermatology Conference–Abstracts and Posters

November Read more

#10-Treat-to-Target Outcomes and Measures of Treatment Success in Three Phase 3 Trials of Tapinarof Cream 1% Once Daily for Mild to Severe Plaque Psoriasis

SDPA Presents 20th Annual Fall Dermatology Conference–Abstracts and Posters

November Read more

#09-Tapinarof Cream 1% Once Daily for Plaque Psoriasis: Improvements in Quality of Life and Clinical Efficacy in Two Pivotal Phase 3 Trials

SDPA Presents 20th Annual Fall Dermatology Conference–Abstracts and Posters

November Read more

#15-Long-term Improvements in Disease Severity, Itch, and Quality of Life after 3 Years of Tralokinumab Treatment in Adults with Moderate-to-severe Atopic Dermatitis

SDPA Presents 20th Annual Fall Dermatology Conference–Abstracts and Posters

November Read more